Drugs

Final Guidance for Industry: Use of Electronic Health Record Data in Clinical Investigations – December 6, 2018

Image of SBIA Webinar 2016 

Thursday, December 6, 2018
1:00pm - 2:00pm (Eastern)
 

The Food and Drug Administration, Center for Drug Evaluation and Research and Small Business and Industry Assistance (CDER SBIA), welcomes you to our webinar series.

These events focus on a specific topic and provide an opportunity for small business and industry entities to learn more about the FDA and basic drug regulation.  The webinars support CDER SBIA’s mission of promoting productive interaction with regulated industry by assisting small pharmaceutical business and industry with information relating to the development and regulation of human drug products.

Issuing the guidance for industry on the use of electronic heath record (EHR) data in clinical investigations is part of the agency’s commitment to furthering the advancement and usage of new technologies in scientific and regulatory processes. The goals of the guidance are to:

  • Modernize and streamline clinical investigations.
  • Promote the interoperability of EHR and EDC systems by encouraging sponsors and health care organizations to work with EHR and electronic data capture (EDC) vendors to further advance the interoperability and integration of EHRs and EDC systems.

This webinar will provide insight on FDA’s recommendations on the use of EHR data in FDA-regulated clinical investigations.

WHY ATTEND?

  • Hear directly from the FDA experts on using EHR data in clinical investigations
  • Take a deep dive into the recommendations presented in the final guidance document

WHO SHOULD ATTEND?

  • Regulatory affairs professionals
  • Researchers
  • Clinical investigators
  • Sponsors
  • CROs
  • IRBs
  • Foreign regulators
  • Consultants
  • Clinical research coordinators
  • EHR and EDC technology vendors
  • Other stakeholders interested in using EHR data in clinical investigations

CONTINUING EDUCATION

    • This one-hour live webinar is RAPS eligible for up to 1.0 credit towards a participant’s RAC recertification upon full completion.
    • This event is SQA approved for 0.25 non-GCP or non-GLP units per 1 hour towards RQAP re-registration.           
    • Attendance Certificates are only available for TWO WEEKS after the event. Please note that the credit is only available for participation in the live event and not for watching the recording afterwards.

 

For questions concerning the webinar, please contact CDER SBIA at:
(866)-405-5367 | (301)-796-6707

If you've never used Connect Pro, get a quick overview: http://www.adobe.com/go/connectpro_overview
Test your connection prior to the day of the event: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm

Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

Page Last Updated: 12/12/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English